• Home>About Livzon>Company Profile

    Profile of Zhuhai Livzon Diagnostics Inc.
    Zhuhai Livzon Diagnostics Inc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of the listed company, Livzon Pharmaceutical Group (A-share and H-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. Livzon Diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in China, a national high-tech enterprise.

    Livzon Diagnostics has established many technical platforms such as Enzyme-linked Immunoassay, lateral flow chromatography, Microorganisms testing, Molecular testing, Multiple-detection Immunoassay, Single-test Chemiluminescence immunoassay, Mast Cell Degranulation Test for Allergy, etc. Meanwhile, Livzon Diagnostics also has fully automatic equipment development capability. The products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. Therefore, Livzon Diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

    Zhuhai Livzon Diagnostics Inc.  has equipped with its industrialization base for Research and Development, Production and Office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for Research and Development, which attracts professional elite talents from Laboratory Science, Biological engineering and many other fields. Zhuhai Livzon Diagnostics Inc. owns 5 Research and Development teams spread in 3 Research and Development centers, which located in Zhuhai, Shanghai and Suzhou city. The total Research and Development personnel accounted for nearly 20% , meanwhile the annual Research and Development investment reaches more than 10% of Sales Revenue. Beside its independent Research and Development, Zhuhai Livzon Diagnostics Inc. has established long-term successful cooperation with many first-class International Biomedical Enterprises such as Fujirebro from Japan, Siemens in Germany, and MP company (USA), which has enhanced its comprehensive service capabilities. Zhuhai Livzon Diagnostics Inc. has won the title of honor as "National High-tech Enterprises", "In vitro diagnostic Engineering Technology Research Center of Guangdong Province ", "Guangdong Provincial Enterprise Technology Center", "Innovative Enterprises of Guangdong Province " and the national "Post-doctoral Research Station". With a complete quality management system in production, Zhuhai Livzon Diagnostics Inc. has well achieved the national GMP certification, GSP certification and ISO13485/ISO9001 certification.
    Livzon Overview
    R&D centers
    R&D teams
    scientific research personnel
    personnel with master degree
    R&D land area (m2)
    作為中國IVD行業的先行者,麗珠試劑服務產品涵蓋了傳染性疾病、呼吸道感染、腫瘤標志物檢測、藥物濃度監測、自身免疫、過敏原檢測及血液安全等眾多領域,在呼吸道感染、傳染性疾病、藥物濃度監測等領域的市場占有率處于國內領先地位,多項產品市場占有率高達50%-90%。在2019年底中國爆發新型冠狀病毒的第一時間,麗珠試劑便投入研發,迅速研制出新型冠狀病毒(2019-nCoV)IgM / IgG抗體檢測試劑盒(膠體金法)產品,并獲證上市,助力國內外疫情防控。
    Livzon Diagnostics Technology Theme Exhibition Hall
    Focus on disease research · Create new detection technology